Amgen Email Format
Biotechnology ResearchCalifornia, United States10001+ Employees
Amgen is a biotechnology research company based in Thousand Oaks, California, focused on applying biology and technology to address serious diseases. It notes a historical role in establishing the biotechnology industry and emphasizes ongoing innovation driven by human genetic data to extend what is medically knowable. Through sustained research and development, Amgen maintains a robust pipeline of medicines aimed at cancer, cardiovascular disease, osteoporosis, inflammatory conditions, and rare diseases. Amgen sits among major market indices, being a constituent of the Dow Jones Industrial Average and part of the Nasdaq-100. In June 2026, the company announced it had engaged an external research firm to independently review data for Tavneos after regulators proposed withdrawing it from the market. The company has received industry recognition, including Fast Company naming it one of the World’s Most Innovative Companies in 2024 and Forbes listing it among America’s Best Large Employers.